There are 2949 resources available
1067P - Cardiac-related deaths in immune-dependent treatment: A population-based study of the non-immunotherapy vs immunotherapy era
Presenter: Mohammed Hussein Omar Safi
Session: E-Poster Display
Resources:
Abstract
1068P - Rescue chemotherapy (CT) after immune-oncology (IO) drugs in patients (pts) with refractory solid tumours: A propensity score (PS) matched cohort study
Presenter: Vladimir Galvão
Session: E-Poster Display
Resources:
Abstract
1070P - Neutrophil-to-lymphocyte ratio predicts survival in patients with cancer of unknown primary
Presenter: Konrad Tałasiewicz
Session: E-Poster Display
Resources:
Abstract
1069P - A multicenter phase II study of nivolumab combined with ipilimumab in patients with pediatric solid tumours in adulthood (GETHI021)
Presenter: Xabier Mielgo Rubio
Session: E-Poster Display
Resources:
Abstract
1071P - Sex and age-related bias in estimating tumour mutation burden from targeted panel sequencing data
Presenter: Shi-jian Zhang
Session: E-Poster Display
Resources:
Abstract
1072P - Beyond classical surrogate endpoints in trials of PD1/PD-L1 immune checkpoint inhibitors (ICI) plus chemotherapy (CT)
Presenter: Guillermo Villacampa Javierre
Session: E-Poster Display
Resources:
Abstract
1073TiP - A phase I, first-in-human, multicenter, open-label, dose-escalation study of IPH5201 as monotherapy or in combination with durvalumab ± oleclumab in advanced solid tumours
Presenter: John Powderly
Session: E-Poster Display
Resources:
Abstract
1074TiP - SGNTGT-001: A phase I study of SGN-TGT, an effector-function enhanced monoclonal antibody (mAb), in advanced malignancies
Presenter: Elena Garralda
Session: E-Poster Display
Resources:
Abstract
1075TiP - MEDI1191, a novel IL-12 mRNA therapy for intratumoral (IT) injection for advanced solid tumours
Presenter: Thomas Marron
Session: E-Poster Display
Resources:
Abstract
1084P - Cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma (mCSCC): Preliminary safety and efficacy results from a phase I clinical trial
Presenter: Philip Clingan
Session: E-Poster Display
Resources:
Abstract